Citations

Clear

750 citation(s) found for "Lowe, Val".

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
Gunter, Jeffrey L. , Lowe, Val J. , Weigand, Stephen D. , Vemuri, Prashanthi , Senjem, Matthew L. , Petersen, Ronald C. , Jack, Clifford R. , Jack, Clifford R , Vemuri, Prashanthi , Senjem, Matthew L , Schwarz, Christopher G. , Knopman, David S.

Mayo Clinic

Journal of Alzheimer's Disease | November 23, 2018 | Volume: 67 | Issue: 1 | Pages: 181-195

10.3233/jad-180749 | PMID 30475770 Get It

Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia
Vassilaki, Maria , Aakre, Jeremiah A. , Kremers, Walter K. , Mielke, Michelle M. , Geda, Yonas E. , Coloma, Preciosa M. , Schäuble, Barbara, Vemuri, Prashanthi , Lowe, Val J. , Jack, Clifford R. , Petersen, Ronald C. , Roberts, Rosebud O., Jack, Clifford R , Mielke, Michelle M , Vemuri, Prashanthi , Geda, Yonas E , Kremers, Walter K , Machulda, Mary M. , Knopman, David S.

Mayo Clinic

Journal of the American Geriatrics Society | November 21, 2018 | Volume: 66 | Issue: 12 | Pages: 2274-2281

10.1111/jgs.15577 | PMID 30462843 Get It

Objectives To examine the cross‐sectional association between functional performance and Alzheimer's disease (AD) neuroimaging biomarkers in individuals without dementia (cognitively unimpaired (CU), and those with mild cognitive impairment (MCI)). Design Cross‐sectional. Setting Olmsted County, Minnesota. Participants Population‐based Mayo Clinic Study of Aging (MCSA) participants (aged ≥ 50, mean age 71.3 ± 10.2; 53.4% male; 28.3% apolipoprotein (APO)E ε4 allele carriers, 1,578 CU, 204 MCI) who underwent 11 C‐Pittsburgh compound B ( 11 C‐PiB) positron emission tomography (PET) (N=1,782). Measurements We defined an abnormal (high) 11 C‐PiB‐PET retention ratio as a standardized uptake value ratio greater than 1.42 (high amyloid; A+), abnormal (reduced) AD signature cortical thickness (neurodegeneration; N+) as less than 2.67 mm (MRI measurement), and biomarker groups according to the combination of abnormality (or not) for amyloid accumulation (A+/A–) and neurodegeneration (N+/N–). Functional performance was assessed using the Clinical Dementia Rating (CDR) Sum of Boxes (SOB) for functional domains and the Functional Activities Questionnaire (FAQ). Results Participants with a CDR‐SOB (functional) score greater than 0 were almost 4 times as likely to have N + (odds ratio (OR)=3.92, 95% confidence interval (CI)=1.77–8.67, adjusting for age, sex, education, global cognitive z‐score, and APOE ε4 allele status; p<.001) and those with a FAQ score greater than 0 were 1.5 times as likely to have A + (OR=1.48, 95% CI=1.04–2.11, p=.03). Higher FAQ scores were associated with greater odds of A+N + and A–N + in CU participants. Conclusion The findings of this cross‐sectional study supplement limited available information that supports an association between functional performance and AD neuroimaging biomarkers very early in the dementia pathophysiology. The associations should be validated in longitudinal studies. J Am Geriatr Soc 66:2274–2281, 2018 .
RTHP-02. IMPACT OF 18F-DOPA PET ON RADIOTHERAPY TARGET VOLUMES FOR NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS; PRELIMINARY RESULTS OF A PHASE II DOSE-ESCALATION TRIAL
Brinkmann, Debra H. , Pafundi, Deanna, Lowe, Val J. , Yan, Elizabeth , Brown, Paul D. , Zakhary, Mark J. , Seaberg, Maasa , Tseung, Hok Seum Wan Chan, Hunt, Christopher H. , Zhang, Yan, Sarkaria, Jann N. , Laack, Nadia N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi225-vi225

10.1093/neuonc/noy148.934 Get It

ACTR-12. PRELIMINARY SAFETY AND EFFICACY OF A PHASE II TRIAL OF 18F-DOPA PET-GUIDED, DOSE-ESCALATED RADIOTHERAPY IN THE TREATMENT OF GLIOBLASTOMA
Pafundi, Deanna, Anderson, S. Keith , Zakhary, Mark J. , Tseung, Hok Seum Wan Chan, Lowe, Val J. , Yan, Elizabeth , Kizilbash, Sani H. , Uhm, Joon H. , Hu, Leland , Brown, Paul D. , Buckner, Jan C. , Brinkmann, Debra H. , Kizilbash, Sani H , Laack, Nadia N. , Hunt, Christopher H. , Kaufmann, Timothy J. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi13-vi13

10.1093/neuonc/noy148.046 Get It

Patterns of Neuropsychological Dysfunction and Cortical Volume Changes in Logopenic Aphasia
Owens, Tyler E., Boland, Sarah, Martin, Peter R. , Lowe, Val J. , Jack, Clifford R. , Whitwell, Jennifer L. , Josephs, Keith A. , Jack, Clifford R , Machulda, Mary M. , Duffy, Joseph R. , Strand, Edythe A. , Clark, Heather M.

Mayo Clinic

Journal of Alzheimer’s Disease | October 23, 2018 | Volume: 66 | Issue: 3 | Pages: 1015-1025

10.3233/jad-171175 | PMID 30372673 Get It

Background: Neuropsychological assessment can add essential information to the characterization of individuals presenting with the logopenic variant of primary progressive aphasia (lvPPA). Objective: This study examined the neuropsychological characteristics of lvPPA patients. We also examined differences in regional and whole brain atrophy based on neuropsychological profiles. Methods: We conducted a hierarchical cluster analysis on memory, executive functioning, and visuospatial neuropsychological test data for 56 individuals with lvPPA. We then compared resultant clusters to left middle temporal, inferior parietal, and superior parietal regions-of-interest using multivariate analysis of covariance. We also performed voxel-level analyses. Results: We identified three clusters characterized as lvPPA with no neurocognitive impairment ( n = 5), lvPPA with mild neurocognitive deficits ( n = 23), and lvPPA with marked cognitive deficits ( n = 28). WAB-AQ was associated with left middle temporal volume. Superior parietal volumes were smaller for the lvPPA group with marked cognitive symptoms compared to the less severe groups. Voxel-level analyses showed greater atrophy in temporal, parietal, lateral occipital, and frontal regions, left worse than right. Age, disease duration, gender, WAB-AQ, and PiB-PET did not account for differences between groups. Conclusions: LvPPA patients without cognitive deficits in other domains were relatively uncommon while 50% of our sample exhibited pronounced neurocognitive deficits outside the language domain. Pronounced cognitive deficits in lvPPA are associated with widespread atrophy, left worse than right. Our study underscores the importance of examining neuropsychological function in addition to language in patients with lvPPA.
P4‐319: CLINICAL FEATURES, CSF BIOMARKERS, MOLECULAR IMAGING, AND PATHOLOGY IN DYSEXECUTIVE ALZHEIMER'S DISEASE
Przybelski, Scott A. , Savica, Rodolfo , Radford, Jonathan Graff, Drubach, Daniel A., Josephs, Keith A. , Lowe, Val J. , Petersen, Ronald C. , Mantyh, William G. , Botha, Hugo , Machulda, Mary M. , Murray, Melissa E. , Polsinelli, Angelina J. , Boeve, Bradley F. , Knopman, David S. , Jack, Clifford R. , Jones, David T.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_30 | Pages: No page available

10.1016/j.jalz.2018.07.142 Get It

P4‐318: PET MEASUREMENTS OF PHF TAU BURDEN IN COGNITIVELY UNIMPAIRED PERSONS WITH TWO, ONE AND NO COPIES OF THE APOE4 ALLELE
Goradia, Dhruman D., Protas, Hillary , Devadas, Vivek, Tariot, Pierre N. , Lowe, Val J. , Petersen, Ronald C. , Caselli, Richard J. , Reiman, Eric M. , Ghisays, Valentina , Bauer, Robert, Knopman, David S. , Jack, Clifford R. , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_30 | Pages: No page available

10.1016/j.jalz.2018.07.141 Get It

P4‐301: REGION‐LEVEL RELATIONSHIPS BETWEEN TAU, AMYLOID, HYPOMETABOLISM AND ATROPHY IN ATYPICAL ALZHEIMER'S DISEASE
Sintini, Irene , Martin, Peter R. , Graff‐Radford, Jonathan , Spychalla, Anthony J., Drubach, Daniel A., Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Schwarz, Christopher G. , Machulda, Mary M. , Senjem, Matthew L. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_30 | Pages: No page available

10.1016/j.jalz.2018.07.124 Get It

O2‐13‐06: PITTSBURGH COMPOUND‐B BINDING IN WHITE MATTER HYPERINTENSITIES IS ASSOCIATED WITH LOSS OF WHITE MATTER INTEGRITY ON DTI
Lowe, Val J. , Reid, Robert I. , Przybelski, Scott A. , Lesnick, Timothy G. , Kantarci, Orhun H. , Petersen, Ronald C. , Reid, Robert I , Zeydan, Burcu , Schwarz, Christopher G. , Kremers, Walter K. , Senjem, Matthew L. , Vemuri, Prashanthi , Knopman, David S. , Jack, Clifford R. , Kantarci, Kejal

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_12 | Pages: No page available

10.1016/j.jalz.2018.06.2717 Get It

O2‐13‐01: INCIDENCE OF CEREBRAL MICROBLEEDS AND AMYLOID BURDEN: THE MAYO CLINIC STUDY OF AGING
Radford, Jonathan Graff, Przybelski, Scott A. , Lesnick, Timothy G. , Brown, Robert D. , Roberts, Rosebud O., Lowe, Val J. , Petersen, Ronald C. , Vemuri, Prashanthi , Rabinstein, Alejandro A. , Flemming, Kelly D. , Knopman, David S. , Mielke, Michelle M. , Kremers, Walter K. , Jones, David T. , Huston, John , Jack, Clifford R. , Kantarci, Kejal

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_12 | Pages: No page available

10.1016/j.jalz.2018.06.2712 Get It